Literature DB >> 10806142

Airway hyperresponsiveness in elite athletes.

J B Langdeau1, H Turcotte, D M Bowie, J Jobin, P Desgagné, L P Boulet.   

Abstract

It has been suggested that high-level training could contribute to the development of airway hyperresponsiveness (AHR), but the comparative effects of different sports on airway function remains to be determined. We evaluated 150 nonsmoking volunteers 18 to 55 yr of age; 100 athletes divided into four subgroups of 25 subjects each according to the predominant estimated hydrocaloric characteristic of ambient air inhaled during training: dry air (DA), cold air (CA), humid air (HA) and a mixture of dry and humid air (MA), and 50 sedentary subjects. Each subject had a respiratory questionnaire, a methacholine challenge, allergy skin-prick tests, and heart rate variability recording for evaluation of parasympathetic tone. The athletes had a 49% prevalence of AHR (PC(20) < 16 mg/ml), with a mean PC(20) of 16.9 mg/ml, compared with 28% (PC(20): 35.4) in sedentary subjects (p = 0.009). The prevalence (%) of AHR and mean PC(20) (mg/ml) varied as followed in the four subgroups of athletes: DA: 32% and 30.9; CA: 52% and 15.8; HA: 76% and 7.3; and MA: 32% and 21.5 (p = 0.002). The estimated parasympathetic tone was higher in athletes (p < 0.001), but this parameter showed only a weak correlation with PC(20) (r = -0.17, p = 0.04). This study has shown a significantly higher prevalence of AHR in athletes than in the control group because of the higher prevalence in the CA and HA groups. Parasympathetic activity may act as modulator of airway responsiveness, but the increased prevalence of AHR in our athlete population may be related to the type and possibly the content of inhaled air during training.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10806142     DOI: 10.1164/ajrccm.161.5.9909008

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  19 in total

1.  Prevalence of obstructive airflow limitation in Irish collegiate athletes.

Authors:  E Smith; N Mahony; B Donne; M O'Brien
Journal:  Ir J Med Sci       Date:  2002 Oct-Dec       Impact factor: 1.568

Review 2.  Asthma, outdoor air quality and the Olympic Games.

Authors:  Donald C McKenzie; Louis-Philippe Boulet
Journal:  CMAJ       Date:  2008-08-07       Impact factor: 8.262

3.  High-dose inhaled terbutaline increases muscle strength and enhances maximal sprint performance in trained men.

Authors:  Morten Hostrup; Anders Kalsen; Jens Bangsbo; Peter Hemmersbach; Sebastian Karlsson; Vibeke Backer
Journal:  Eur J Appl Physiol       Date:  2014-08-12       Impact factor: 3.078

Review 4.  Prevalence and mechanisms of development of asthma and airway hyperresponsiveness in athletes.

Authors:  J B Langdeau; L P Boulet
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 5.  Asthma, airway inflammation and treatment in elite athletes.

Authors:  Ilkka Helenius; Aki Lumme; Tari Haahtela
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

6.  The determinants of prevalence of health complaints among young competitive swimmers.

Authors:  Benoit Lévesque; Jean-François Duchesne; Suzanne Gingras; Robert Lavoie; Denis Prud'Homme; Emmanuelle Bernard; Louis-Philippe Boulet; Pierre Ernst
Journal:  Int Arch Occup Environ Health       Date:  2006-04-04       Impact factor: 3.015

Review 7.  The respiratory health of swimmers.

Authors:  Valérie Bougault; Julie Turmel; Benoît Levesque; Louis-Philippe Boulet
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

8.  Seasons can influence the results of the methacholine challenge test.

Authors:  Bruno Sposato; Marco Scalese; Andrea Pammolli; Raffaele Scala; Mario Naldi
Journal:  Ann Thorac Med       Date:  2012-04       Impact factor: 2.219

Review 9.  Exercise-induced bronchoconstriction: pathogenesis.

Authors:  Sandra D Anderson; Pascale Kippelen
Journal:  Curr Allergy Asthma Rep       Date:  2005-03       Impact factor: 4.919

10.  Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist.

Authors:  James P Kemp
Journal:  Ther Clin Risk Manag       Date:  2009       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.